Avoid common mistakes on your manuscript.
Correction to: Osteoporosis International
In this article the first reference in the Discussion section was incorrectly given as 19 but should have been 20. And all subsequent references (21 to 37) should have been one number higher.
The legend for Fig. 1 (B) and (C) were inadvertently swapped; the figure legend should have been “ibandronate (B), alendronate (C)”
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
About this article
Cite this article
Everts-Graber, J., Bonel, H., Lehmann, D. et al. Correction to: Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study. Osteoporos Int 34, 1975 (2023). https://doi.org/10.1007/s00198-023-06887-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-023-06887-4